Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
Rosenberg AJ, Agrawal N, Pearson A, Gooi Z, Blair E, Cursio J, Juloori A, Ginat D, Howard A, Chin J, Kochanny S, Foster C, Cipriani N, Lingen M, Izumchenko E, Seiwert TY, Haraf D, Vokes EE.
Rosenberg AJ, et al. Among authors: gooi z.
Oral Oncol. 2021 Nov;122:105566. doi: 10.1016/j.oraloncology.2021.105566. Epub 2021 Oct 18.
Oral Oncol. 2021.
PMID: 34662771
Free PMC article.
Clinical Trial.